Petmed Express Inc
NASDAQ:PETS

Watchlist Manager
Petmed Express Inc Logo
Petmed Express Inc
NASDAQ:PETS
Watchlist
Price: 4.97 USD -2.55% Market Closed
Market Cap: 102.7m USD
Have any thoughts about
Petmed Express Inc?
Write Note

Petmed Express Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Petmed Express Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Petmed Express Inc
NASDAQ:PETS
Operating Income
-$1.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DoorDash Inc
NASDAQ:DASH
Operating Income
-$577m
CAGR 3-Years
-10%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Chewy Inc
NYSE:CHWY
Operating Income
$102.7m
CAGR 3-Years
101%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ETSY Inc
NASDAQ:ETSY
Operating Income
$367.1m
CAGR 3-Years
-9%
CAGR 5-Years
32%
CAGR 10-Years
N/A
eBay Inc
NASDAQ:EBAY
Operating Income
$2.5B
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
3%
Amazon.com Inc
NASDAQ:AMZN
Operating Income
$60.6B
CAGR 3-Years
29%
CAGR 5-Years
33%
CAGR 10-Years
90%
No Stocks Found

Petmed Express Inc
Glance View

Market Cap
102.7m USD
Industry
Retail

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 212 full-time employees. The company went IPO on 2000-04-06. The firm's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. The company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The firm's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

PETS Intrinsic Value
5.6 USD
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Petmed Express Inc's Operating Income?
Operating Income
-1.3m USD

Based on the financial report for Sep 30, 2024, Petmed Express Inc's Operating Income amounts to -1.3m USD.

What is Petmed Express Inc's Operating Income growth rate?
Operating Income CAGR 1Y
87%

Over the last year, the Operating Income growth was 87%.

Back to Top